According to Reuters.com, “Teva Pharmaceutical Industries Ltd has offered concessions to allay EU antitrust concerns over its $40.5 billion bid for Allergan’s generics unit which will cement its position as the world’s largest generics drugmaker.” For more information, please visit: http://www.reuters.com/article/us-allergan-m-a-teva-pharm-ind-eu-idUSKCN0VS157